Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Cost-minimization analysis of alemtuzumab compared to fingolimod and natalizumab for the treatment of active relapsing-remitting multiple sclerosis in the Netherlands.

Piena MA, Heisen M, Wormhoudt LW, Wingerden JV, Frequin STFM, Uitdehaag BMJ.

J Med Econ. 2018 Oct;21(10):968-976. doi: 10.1080/13696998.2018.1489255. Epub 2018 Jul 9.

PMID:
29911917
2.

Prevention of anaemia by early intervention with once weekly epoetin alfa during chemotherapy.

Schouwink JH, Codrington H, Sleeboom HP, Kerkhofs LG, Wormhoudt LW.

Eur J Cancer. 2008 Apr;44(6):819-29. doi: 10.1016/j.ejca.2008.02.017. Epub 2008 Mar 17.

PMID:
18343652
5.

Effects of early intervention with epoetin alfa on transfusion requirement, hemoglobin level and survival during platinum-based chemotherapy: Results of a multicenter randomised controlled trial.

Savonije JH, van Groeningen CJ, van Bochove A, Honkoop AH, van Felius CL, Wormhoudt LW, Giaccone G.

Eur J Cancer. 2005 Jul;41(11):1560-9.

PMID:
15953714
6.

A physiologically-based pharmacokinetic(PB-PK) model for ethylene dibromide: relevance of extrahepatic metabolism.

Hissink AM, Wormhoudt LW, Sherratt PJ, Hayes JD, Commandeur JN, Vermeulen NP, van Bladeren PJ.

Food Chem Toxicol. 2000 Aug;38(8):707-16.

PMID:
10908818
7.
8.

Disposition of 1,2-[14C]Dibromoethane in male Wistar rats.

Wormhoudt LW, Hissink AM, Commandeur JN, van Bladeren PJ, Vermeulen NP.

Drug Metab Dispos. 1998 May;26(5):437-47.

PMID:
9571225
9.

Toxicity of fotemustine in rat hepatocytes and mechanism-based protection against it.

Vermeulen NP, Commandeur JN, Groot EJ, Wormhoudt LW, Ramnatshing S, Li QJ, Brakenhoff JP.

Chem Biol Interact. 1998 Apr 3;110(3):139-58.

PMID:
9609383
10.

Urinary thiodiacetic acid. A selective biomarker for the cytochrome P450-catalyzed oxidation of 1,2-dibromoethane in the rat.

Wormhoudt LW, Commandeur JN, Ploemen JH, Abdoelgafoer RS, Makansi A, Van Bladeren PJ, Vermeulen NP.

Drug Metab Dispos. 1997 Apr;25(4):508-15.

PMID:
9107551
11.

The use of human in vitro metabolic parameters to explore the risk assessment of hazardous compounds: the case of ethylene dibromide.

Ploemen JP, Wormhoudt LW, Haenen GR, Oudshoorn MJ, Commandeur JN, Vermeulen NP, de Waziers I, Beaune PH, Watabe T, van Bladeren PJ.

Toxicol Appl Pharmacol. 1997 Mar;143(1):56-69.

PMID:
9073592
12.

Inter-individual variability in the oxidation of 1,2-dibromoethane: use of heterologously expressed human cytochrome P450 and human liver microsomes.

Wormhoudt LW, Ploemen JH, de Waziers I, Commandeur JN, Beaune PH, van Bladeren PJ, Vermeulen NP.

Chem Biol Interact. 1996 Sep 6;101(3):175-92.

PMID:
8870687
13.

In vitro inhibition of rat and human glutathione S-transferase isoenzymes by disulfiram and diethyldithiocarbamate.

Ploemen JP, van Iersel ML, Wormhoudt LW, Commandeur JN, Vermeulen NP, van Bladeren PJ.

Biochem Pharmacol. 1996 Jul 26;52(2):197-204.

PMID:
8694843
14.

Molecular mechanisms of toxic effects of fotemustine in rat hepatocytes and subcellular rat liver fractions.

Brakenhoff JP, Commandeur JN, Wormhoudt LW, Groot EJ, Vermeulen NP.

Carcinogenesis. 1996 Apr;17(4):715-24.

PMID:
8625482
15.

Cytochrome P450 catalyzed metabolism of 1,2-dibromoethane in liver microsomes of differentially induced rats.

Wormhoudt LW, Ploemen JH, Commandeur JN, van Ommen B, van Bladeren P, Vermeulen NP.

Chem Biol Interact. 1996 Jan 5;99(1-3):41-53.

PMID:
8620578
16.

Polymorphism in the glutathione conjugation activity of human erythrocytes towards ethylene dibromide and 1,2-epoxy-3-(p-nitrophenoxy)-propane.

Ploemen JH, Wormhoudt LW, van Ommen B, Commandeur JN, Vermeulen NP, van Bladeren PJ.

Biochim Biophys Acta. 1995 Apr 13;1243(3):469-76.

PMID:
7727522

Supplemental Content

Loading ...
Support Center